05/13/2024
3:33 PM | Ikena Oncology (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/26/2024
3:22 PM | Ikena Oncology (Filer)
| Form DEF 14A | |
03/12/2024
6:48 AM | Ikena Oncology (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/12/2024
6:30 AM | Ikena Oncology (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/11/2024
7:19 AM | FMR LLC (Filed by)
Ikena Oncology (Subject)
| Form SC 13G/A | |
02/21/2024
3:29 PM | Ikena Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
3:57 PM | CITADEL ADVISORS LLC (Filed by)
Ikena Oncology (Subject)
| Form SC 13G/A | |
|
02/14/2024
8:47 AM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Ikena Oncology (Subject)
| Form SC 13G/A | |
02/09/2024
8:16 AM | Ikena Oncology (Subject)
| Form SC 13G/A | |
02/02/2024
4:15 PM | Ecsedy Jeffrey (Reporting)
Ikena Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
4:07 PM | Ikena Oncology (Issuer)
Manfredi Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
4:08 PM | Ikena Oncology (Issuer)
Marango Jotin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
3:26 PM | Ikena Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
6:09 AM | Ikena Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
6:30 AM | Ikena Oncology (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/19/2023
2:33 PM | GILEAD SCIENCES, INC. (Filed by)
Ikena Oncology (Subject)
| Form SC 13G | |
10/11/2023
4:10 PM | Ikena Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2023
3:05 PM | Ikena Oncology (Filer)
| Form DEF 14A | |
09/21/2023
4:02 PM | Ikena Oncology (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
| Form 4/A | |
09/21/2023
4:04 PM | Bonita David P (Reporting)
Ikena Oncology (Issuer)
| Form 4/A | |
09/21/2023
3:52 PM | Ikena Oncology (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13D/A | |
09/15/2023
3:05 PM | Ikena Oncology (Filer)
| Form PRE 14A | |
09/14/2023
8:22 PM | Ikena Oncology (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/14/2023
8:17 PM | Bonita David P (Reporting)
Ikena Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/14/2023
3:21 PM | Ikena Oncology (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13D/A | |
09/12/2023
3:11 PM | Ikena Oncology (Filer)
| Form 424B5 | |
09/10/2023
11:15 PM | Ikena Oncology (Filer)
| Form EFFECT | |
08/10/2023
6:00 AM | Ikena Oncology (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2023
7:02 AM | Ikena Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/30/2023
4:15 PM | Ikena Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2023
3:30 PM | FORMELA JEAN FRANCOIS (Reporting)
Ikena Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
3:30 PM | Ikena Oncology (Issuer)
Wooster Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
3:30 PM | Bonita David P (Reporting)
Ikena Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
3:30 PM | Ikena Oncology (Issuer)
Koehler Maria (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
3:30 PM | Ikena Oncology (Issuer)
Stampacchia Otello (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
3:30 PM | Hughes Owen (Reporting)
Ikena Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
3:30 PM | Dukes Iain D. (Reporting)
Ikena Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
